Cancer screening and better clinical diagnosis should not be in competition
Cox at al.1 point to limitations in colposcopy services for cervical cancer and treatment services for breast cancer, and state that the limitations of clinical services-particularly for colonoscopy- necessitated a reduction in test sensitivity and a narrower age range for the bowel cancer screening...
Gespeichert in:
| Veröffentlicht in: | New Zealand medical journal 2023-07, Vol.136 (1578), p.9-11 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 11 |
|---|---|
| container_issue | 1578 |
| container_start_page | 9 |
| container_title | New Zealand medical journal |
| container_volume | 136 |
| creator | Elwood, Mark |
| description | Cox at al.1 point to limitations in colposcopy services for cervical cancer and treatment services for breast cancer, and state that the limitations of clinical services-particularly for colonoscopy- necessitated a reduction in test sensitivity and a narrower age range for the bowel cancer screening programme when first introduced. If the extra work is not adequately resourced, diagnostic and treatment services for other patients will be disadvantaged. [...]the time from diagnosis to surgery in breast cancer for all patients has been increasing, with the proportion having surgery within 31 days dropping from 56% to 37% between 2004 and 2019, even before COVID-19.8 The clinical diagnosis route in New Zealand is far from satisfactory. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study. |
| doi_str_mv | 10.26635/6965.e1578 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2835275447</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2837130252</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-c03ca88e8228d74fff4690290e56e03614f130af6f2f27fb09970eaab41f6d473</originalsourceid><addsrcrecordid>eNpd0E1LxDAQBuAgiruunrxLwIsgXfPRJO1RFr9wwYueS5pO1ixtsibtwX9vd1dFPM0wPMwML0LnlMyZlFzcyFKKOVChigM0pVSJrFBUHv7pJ-gkpTUhTIiSHKMJVznNieJT9LzQ3kDEyUQA7_wKa9_gGvp-HJrWeWd0ixunVz4kl3B6D0PbYB_6EWHnsQndBnrXu-BP0ZHVbYKz7zpDb_d3r4vHbPny8LS4XWaGU9ZnhnCjiwIKxopG5dbaXJaElQSEBMIlzS3lRFtpmWXK1qQsFQGt65xa2eSKz9DVfu8mho8BUl91LhloW-0hDKliBRdMiXxHL__RdRiiH7_bKjXeYYKN6nqvTAwpRbDVJrpOx8-KkmqXcbXNuNplPOqL751D3UHza39C5V8gqHVC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2837130252</pqid></control><display><type>article</type><title>Cancer screening and better clinical diagnosis should not be in competition</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Elwood, Mark</creator><creatorcontrib>Elwood, Mark</creatorcontrib><description>Cox at al.1 point to limitations in colposcopy services for cervical cancer and treatment services for breast cancer, and state that the limitations of clinical services-particularly for colonoscopy- necessitated a reduction in test sensitivity and a narrower age range for the bowel cancer screening programme when first introduced. If the extra work is not adequately resourced, diagnostic and treatment services for other patients will be disadvantaged. [...]the time from diagnosis to surgery in breast cancer for all patients has been increasing, with the proportion having surgery within 31 days dropping from 56% to 37% between 2004 and 2019, even before COVID-19.8 The clinical diagnosis route in New Zealand is far from satisfactory. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.</description><identifier>ISSN: 1175-8716</identifier><identifier>EISSN: 1175-8716</identifier><identifier>DOI: 10.26635/6965.e1578</identifier><identifier>PMID: 37414073</identifier><language>eng</language><publisher>New Zealand: Pasifika Medical Association Group (PMAG)</publisher><subject>Breast cancer ; Cervical cancer ; Early Detection of Cancer ; Epidemiology ; Humans ; Internet ; Mammography ; Medical diagnosis ; Medical screening ; Mortality ; Neoplasms - diagnosis ; New Zealand ; Primary care ; Quality improvement</subject><ispartof>New Zealand medical journal, 2023-07, Vol.136 (1578), p.9-11</ispartof><rights>Copyright New Zealand Medical Association (NZMA) Jul 7, 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37414073$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elwood, Mark</creatorcontrib><title>Cancer screening and better clinical diagnosis should not be in competition</title><title>New Zealand medical journal</title><addtitle>N Z Med J</addtitle><description>Cox at al.1 point to limitations in colposcopy services for cervical cancer and treatment services for breast cancer, and state that the limitations of clinical services-particularly for colonoscopy- necessitated a reduction in test sensitivity and a narrower age range for the bowel cancer screening programme when first introduced. If the extra work is not adequately resourced, diagnostic and treatment services for other patients will be disadvantaged. [...]the time from diagnosis to surgery in breast cancer for all patients has been increasing, with the proportion having surgery within 31 days dropping from 56% to 37% between 2004 and 2019, even before COVID-19.8 The clinical diagnosis route in New Zealand is far from satisfactory. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.</description><subject>Breast cancer</subject><subject>Cervical cancer</subject><subject>Early Detection of Cancer</subject><subject>Epidemiology</subject><subject>Humans</subject><subject>Internet</subject><subject>Mammography</subject><subject>Medical diagnosis</subject><subject>Medical screening</subject><subject>Mortality</subject><subject>Neoplasms - diagnosis</subject><subject>New Zealand</subject><subject>Primary care</subject><subject>Quality improvement</subject><issn>1175-8716</issn><issn>1175-8716</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpd0E1LxDAQBuAgiruunrxLwIsgXfPRJO1RFr9wwYueS5pO1ixtsibtwX9vd1dFPM0wPMwML0LnlMyZlFzcyFKKOVChigM0pVSJrFBUHv7pJ-gkpTUhTIiSHKMJVznNieJT9LzQ3kDEyUQA7_wKa9_gGvp-HJrWeWd0ixunVz4kl3B6D0PbYB_6EWHnsQndBnrXu-BP0ZHVbYKz7zpDb_d3r4vHbPny8LS4XWaGU9ZnhnCjiwIKxopG5dbaXJaElQSEBMIlzS3lRFtpmWXK1qQsFQGt65xa2eSKz9DVfu8mho8BUl91LhloW-0hDKliBRdMiXxHL__RdRiiH7_bKjXeYYKN6nqvTAwpRbDVJrpOx8-KkmqXcbXNuNplPOqL751D3UHza39C5V8gqHVC</recordid><startdate>20230707</startdate><enddate>20230707</enddate><creator>Elwood, Mark</creator><general>Pasifika Medical Association Group (PMAG)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AYAGU</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20230707</creationdate><title>Cancer screening and better clinical diagnosis should not be in competition</title><author>Elwood, Mark</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-c03ca88e8228d74fff4690290e56e03614f130af6f2f27fb09970eaab41f6d473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Breast cancer</topic><topic>Cervical cancer</topic><topic>Early Detection of Cancer</topic><topic>Epidemiology</topic><topic>Humans</topic><topic>Internet</topic><topic>Mammography</topic><topic>Medical diagnosis</topic><topic>Medical screening</topic><topic>Mortality</topic><topic>Neoplasms - diagnosis</topic><topic>New Zealand</topic><topic>Primary care</topic><topic>Quality improvement</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elwood, Mark</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Australia & New Zealand Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>New Zealand medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elwood, Mark</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer screening and better clinical diagnosis should not be in competition</atitle><jtitle>New Zealand medical journal</jtitle><addtitle>N Z Med J</addtitle><date>2023-07-07</date><risdate>2023</risdate><volume>136</volume><issue>1578</issue><spage>9</spage><epage>11</epage><pages>9-11</pages><issn>1175-8716</issn><eissn>1175-8716</eissn><abstract>Cox at al.1 point to limitations in colposcopy services for cervical cancer and treatment services for breast cancer, and state that the limitations of clinical services-particularly for colonoscopy- necessitated a reduction in test sensitivity and a narrower age range for the bowel cancer screening programme when first introduced. If the extra work is not adequately resourced, diagnostic and treatment services for other patients will be disadvantaged. [...]the time from diagnosis to surgery in breast cancer for all patients has been increasing, with the proportion having surgery within 31 days dropping from 56% to 37% between 2004 and 2019, even before COVID-19.8 The clinical diagnosis route in New Zealand is far from satisfactory. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.</abstract><cop>New Zealand</cop><pub>Pasifika Medical Association Group (PMAG)</pub><pmid>37414073</pmid><doi>10.26635/6965.e1578</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1175-8716 |
| ispartof | New Zealand medical journal, 2023-07, Vol.136 (1578), p.9-11 |
| issn | 1175-8716 1175-8716 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2835275447 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Breast cancer Cervical cancer Early Detection of Cancer Epidemiology Humans Internet Mammography Medical diagnosis Medical screening Mortality Neoplasms - diagnosis New Zealand Primary care Quality improvement |
| title | Cancer screening and better clinical diagnosis should not be in competition |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A19%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer%20screening%20and%20better%20clinical%20diagnosis%20should%20not%20be%20in%20competition&rft.jtitle=New%20Zealand%20medical%20journal&rft.au=Elwood,%20Mark&rft.date=2023-07-07&rft.volume=136&rft.issue=1578&rft.spage=9&rft.epage=11&rft.pages=9-11&rft.issn=1175-8716&rft.eissn=1175-8716&rft_id=info:doi/10.26635/6965.e1578&rft_dat=%3Cproquest_cross%3E2837130252%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2837130252&rft_id=info:pmid/37414073&rfr_iscdi=true |